Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
Chiara Raggi(University of Florence), Pietro Invernizzi(Azienda Ospedaliera San Gerardo)
Cited by 21
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
|Nature Genetics|2013|398
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|392
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma
|Journal of Hepatology|2021|165
Iron levels in polarized macrophages: Regulation of immunity and autoimmunity
|Autoimmunity Reviews|2012|142